690 related articles for article (PubMed ID: 15917102)
1. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
4. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
5. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
7. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
8. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
9. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
[TBL] [Abstract][Full Text] [Related]
10. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
11. Lewy body-related alpha-synucleinopathy in aging.
Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
13. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
[TBL] [Abstract][Full Text] [Related]
14. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
[TBL] [Abstract][Full Text] [Related]
15. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
[TBL] [Abstract][Full Text] [Related]
17. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
18. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).
Mikolaenko I; Pletnikova O; Kawas CH; O'Brien R; Resnick SM; Crain B; Troncoso JC
J Neuropathol Exp Neurol; 2005 Feb; 64(2):156-62. PubMed ID: 15751230
[TBL] [Abstract][Full Text] [Related]
20. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E
Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]